Results 31 to 40 of about 158,005 (297)

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importnace of Lp(a) [PDF]

, 2012
We carried out a genome-wide association study (GWAS) of LDL-c response to statin using data from participants in the Collaborative Atorvastatin Diabetes Study (CARDS; n = 1,156), the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT; n = 895), and the ...
Postmus, Iris, Colhoun, H.M., McKeigue, Paul M, Stanton, A.V., Trompet, S., Hyde, Craig, Colhoun, Helen M, Caulfield, M., Shields, Denis C., Hitman, Graham A, CARDS, Poulter, Neil, Shields, D.C., Sever, P., Chatterjee, Aurobindo, Trompet, Stella, Durrington, Paul N, Deshmukh, H.A., DeMicco, D.A., Calle, Roberto A., Hitman, Graham A., Neil, A., McKeigue, Paul M., Fuller, John H., Postmus, I., Hitman, G.A., DeMicco, David A., Johnson, T., ?, ?, Calle, Roberto A, Betteridge, D.J., Livingstone, Shona, Ford, Ian, McKeigue, P.M., Stanton, Alice V., Jukema, J.W., Johnson, Toby, Durrington, Paul N., Neil, Andrew, PROSPER Investigators, Livingstone, S., Jukema, J. Wouter, ASCOT, Colhoun, Helen, Ford, I., Sever, Peter, Fuller, J.H., Jukema, J Wouter, Caulfield, Mark, Fuller, John H, Chatterjee, A., Deshmukh, Harshal A, Calle, R.A., Hyde, C., Charlton-Menys, V., Poulter, N., Charlton-Menys, Valentine, DeMicco, David A, Betteridge, D John, McKeigue, Paul M.; id_orcid, Betteridge, D. John, Durrington, P.N., Colhoun, Helen M., Shields, Denis C, Deshmukh, Harshal A., Stanton, Alice V   +65 more
core   +1 more source

Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings [PDF]

, 2019
Background: Cardiovascular diseases (CVDs) are the main complication leading to morbidity and mortality among patients with type 2 diabetes mellitus (T2DM).
Elnaem, Mohamed Hassan Abdelaziz, Zaman Huri, Hasniza, Mohd Shah, Azarisman Shah, Nik Mohamed, Mohamad Haniki   +3 more
core   +2 more sources

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus [PDF]

, 2013
Purpose: This paper reports the results of an audit that assessed the prevalence of residual hypertriglyceridemia and the potential need for intensified management among patients with statin-treated type 2 diabetes mellitus (T2DM) in primary care in the ...
Greener, Mark, Munro, Neil, Feher, Michael D.   +2 more
core   +1 more source

Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women. [PDF]

Curr Atheroscler Rep
Purpose of Review: The purpose of this review is to provide an overview of the current status of lipid-lowering therapy utilization and lipid goal attainment in women.
van Oortmerssen JAE, Mulder JWCM, van der Bijl MF, Mijnster RJM, Kavousi M, Roeters van Lennep JE, IMPRESS consortium.   +6 more
europepmc   +2 more sources

Recent Innovations in Lipid-lowering Therapies

Guoji laonian yixue zazhi
Dyslipidemia is a major risk factor for atherosclerotic cardiovascular diseases. Recent advancements in lipid-lowering therapies have seen progress with statins, cholesterol absorption inhibitors, PCSK9 inhibitors, and omega-3 fatty acids becoming widely
Xin Hu, Xiaoming Wang
doaj   +1 more source

Main differences between two highly effective lipid-lowering therapies in subclasses of lipoproteins in patients with acute myocardial infarction

Lipids in Health and Disease, 2021
Background Large observational studies have shown that small, dense LDL subfractions are related to atherosclerotic cardiovascular disease. This study assessed the effects of two highly effective lipid-lowering therapies in the atherogenic subclasses of ...
Leticia C. S. Pinto, Ana P. Q. Mello, Maria C. O. Izar, Nagila R. T. Damasceno, Antonio M. F. Neto, Carolina N. França, Adriano Caixeta, Henrique T. Bianco, Rui M. S. Póvoa, Flavio T. Moreira, Amanda S. F. Bacchin, Francisco A. Fonseca   +11 more
doaj   +1 more source

New possibilities for lipid level control using inclisiran — prospects for interaction between a cardiologist and a neurologist

Рациональная фармакотерапия в кардиологии, 2023
Dyslipidemia is one of the most significant modifiable cardiovascular risk factors. The change in the modern paradigm for dyslipidemia treatment from high-intensity statin therapy to high-intensity lipid-lowering therapy makes it possible to more often ...
A. B. Skiba, M. V. Menzorov, V. D. Puchek, I. M. Buchin, I. I. Polyakov, E. N. Menzorova   +5 more
doaj   +1 more source

Lipid Lowering Therapy According to Clinical Outcomes in Elderly Population

, 2022
A systematic review of statin therapy and other lipid lowering agents and their efficacies in regard to the elderly population. In this review, I have introduced lipid metabolism and storage in the body.
Issa, Rabeh
core  

Lipid-lowering therapy in the outpatient practice

Медицинский совет, 2013
The review focuses on the importance of primary and secondary prevention of cardiovascular disease in outpatient settings, and principles of effective and safe use of modern lipid-lowering drugs.
S. A. Urazgildeyeva
doaj   +1 more source

Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering Therapy [PDF]

, 2023
BACKGROUND The frequency, characteristics and outcomes of patients treated with high-intensity lipid-lowering therapy and showing concomitant atheroma volume reduction, lipid content reduction, and increase in fibrous cap thickness (i.e., "triple ...
van Geuns, Robert-Jan, Shibutani, Hiroki, Otsuka, Tatsuhiko, Kakizaki, Ryota, Spirk, David, Koskinas, Konstantinos C., Engstrøm, Thomas, Lang, Irene, Losdat, Sylvain, Hofbauer, Thomas M, Heg, Dik, Iglesias, Juan, Siontis, Georgios Cm, Lorenz Räber, Biccirè, Flavio G, Häner, Jonas, Iglesias, Juan F., Jonas Häner, Flavio G. Biccirè, Tatsuhiko Otsuka, Sylvain Losdat, David Spirk, Konstantinos C. Koskinas, Bär, Sarah, Stephan Windecker, Lønborg, Jacob, Robert-Jan van Geuns, Jacob Lønborg, Daemen, Joost, Thomas M. Hofbauer, Juan F. Iglesias, George C.M. Siontis, Biccirè, Flavio G., Thomas Engstrøm, Ryota Kakizaki, Sarah Bär, Christoph Kaiser, Hofbauer, Thomas M., Siontis, George C.M., Joost Daemen, Kaiser, Christoph, Stefan Stortecky, van Geuns, Robert Jan, Windecker, Stephan, Hiroki Shibutani, Stortecky, Stefan, Yasushi Ueki, Irene Lang, Dik Heg, Koskinas, Konstantinos C, Räber, Lorenz, Ueki, Yasushi   +51 more
core   +1 more source